Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02349334
Other study ID # 34825
Secondary ID 09/104/16
Status Completed
Phase Phase 3
First received January 23, 2015
Last updated January 27, 2015
Start date January 2012
Est. completion date September 2014

Study information

Verified date January 2015
Source Queen Mary University of London
Contact n/a
Is FDA regulated No
Health authority United Kingdom: National Health Service
Study type Interventional

Clinical Trial Summary

Faecal incontinence occurs when a person passes faeces (stools) without the usual control. It is a distressing condition that is actually very common although under-reported because of embarrassment. Milder symptoms may be managed by treatments such as dietary change, drugs and bowel retraining, but many patients still resort to surgery to improve symptoms. Although several operations exist to treat incontinence e.g. those aiming to repair damaged anal sphincter muscles, it is now clear that these often have poor results.

Two relatively new treatments called sacral nerve stimulation (SNS) and percutaneous tibial nerve stimulation (PTNS) involve sending pulses of electricity to the nerves controlling the bowel and muscles of the anus (anal sphincter).

SNS does this by inserting electrodes in the lower back just above the tailbone and connecting them to an implanted electrical stimulator which is buried in the buttock and acts a bit like a heart pacemaker. SNS is a relatively well-established treatment in specialist centres, which has been used for over 10 years. It has been shown in studies to be successful for faecal incontinence achieving some improvement in at least three quarters of patients. In Europe, this procedure is fast becoming first treatment offered when non-surgical treatments fail. Nevertheless, SNS is not a miracle cure for all, requiring 2 operations, with potential complications and expensive equipment (> £10,000 approx).

PTNS is a newer treatment, which involves electrically stimulating a nerve at the ankle, using a very small needle, as an outpatient (a bit like acupuncture). This sends signals back to the spine region to try and improve symptoms of faecal incontinence. Since this is a newer treatment, fewer studies have been performed to quantify how successful it is, but early results of PTNS suggest that it may be as good as SNS. If this is true, this is very important because it is much less invasive and considerably cheaper than SNS (equipment £500 per patient).

This project will for the first time determine how effective PTNS is in the treatment of patients with faecal incontinence, by comparing it to sham (fake stimulation). This study is a properly designed clinical trial of 212 patients in at least 14 UK Specialist Centres.. The results of this trial will lead to direct benefits for patients and the NHS.


Recruitment information / eligibility

Status Completed
Enrollment 227
Est. completion date September 2014
Est. primary completion date February 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Faecal incontinence sufficiently severe enough to warrant intervention

- Failure of appropriate conservative therapies

- Age = 18 years

Exclusion Criteria:

- Inability to provide informed consent for the research study

- Inability to fill in the detailed bowel diaries required for outcome assessments (this will exclude participants who do not speak / read English)*

- Neurological diseases, such as diabetic neuropathy, multiple sclerosis and Parkinson's disease (any participant with painful peripheral neuropathy)

- Anatomical limitations that would prevent successful placement of needle electrode

- Other medical conditions precluding stimulation: e.g. bleeding disorders, certain cardiac pacemakers, peripheral vascular disease or ulcer, lower leg cellulitis

- Congenital anorectal anomalies or absence of native rectum due to surgery

- A cloacal defect

- Present evidence of external full thickness rectal prolapse

- Previous rectal surgery (rectopexy / resection) done < 12 months ago (24 months for cancer),

- Stoma in situ

- Chronic bowel diseases such as inflammatory bowel disease leading to chronic uncontrolled diarrhoea

- Pregnancy or intention to become pregnant

- Previous experience of SNS or PTNS

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Intervention

Device:
Percutaneous Tibial Nerve Stimulation


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Queen Mary University of London

Outcome

Type Measure Description Time frame Safety issue
Primary Primary outcome: Binary - success or failure based on % patients achieving > or = 50% reduction in faecal incontinence episodes From 2 weekly bowel diaries before and after treatment 3 months No
Secondary Reduction in faecal incontinence episodes 3 months No
Secondary Proportion of patients achieving >25%, >75% and 100% reduction in faecal incotinence episodes 3 months No
Secondary Reduction in Cleveland Clinic Constipation Score 3 months No
See also
  Status Clinical Trial Phase
Recruiting NCT04918329 - Functional Digestive Disorders Observatory
Completed NCT02292628 - Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence Phase 1/Phase 2
Recruiting NCT04612569 - Feasibility and Impact of a Prehabilitation and Rehabilitation Program for the Continuity of Care in Severe Low Anterior Resection Syndrome.
Completed NCT05049486 - Computational Model of SNS (Sacral Nerve Stimulation) Induced Electrical Current Flow Using Tractography Imaging N/A
Completed NCT02782364 - Evaluation of the Fast Fill Technique for Anal Acoustic Reflectometry (AAR) in the Incontinent Anal Sphincter
Withdrawn NCT03257332 - Determining Early Development of Faecal Incontinence and Anorectal Muscle Function After Surgery for Rectal Cancer.
Completed NCT03261622 - Sacral Nerve Stimulation for Faecal Incontinence - Placebo or Clinical Effective N/A
Recruiting NCT03969069 - Assessment of Faecal Incontinence With MAPLe
Recruiting NCT05245565 - Effects of Modified Precision Functional Sphincter-Preserving Surgery (PPS) on Ultralow Rectal Cancer
Completed NCT03078634 - The Multi-disciplinary Treatment of Functional Gut Disorders Study N/A
Recruiting NCT05900726 - Pelvipower for Faecal Incontinence N/A
Recruiting NCT05550675 - Prospective Database of Factors Associated With Faecal vs. Double Incontinence in Patients Referred for High Resolution Anorectal Manometry.
Recruiting NCT04657588 - Controlling Faecal Incontinence With a Novel Anal Device: a Cost-effectiveness Trial N/A
Active, not recruiting NCT04262609 - Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy
Completed NCT05016453 - Long-term Efficacy of Percutaneous Tibial Nerve Stimulation Applied to Patients With Faecal Incontinence.
Completed NCT04007250 - FENIX™ Continence Restoration System Registry
Recruiting NCT06143072 - CArE for OAsI Study: Care Pathways and Anorectal Evaluation for OASI Associated Incontinence
Recruiting NCT04276350 - Efficacy of Acupuncture as a Treatment for Faecal Incontinence N/A
Completed NCT01656720 - A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period Phase 2
Withdrawn NCT00420797 - A Study to Evaluate Topical Phenylephrine Gel in the Management of Faecal Incontinence Phase 3